New in Diabetes Drugs: Healthier Hearts, Improved Glucose Management Research presented at ADAs 2017 conference shows exciting advances in a host of diabetes drugs including heart benefits, improved glucose control, lower cholesterol, weight loss, less hypoglycemia, and more FDA Advisory Panel Recommends Semaglutide for Approval Novo Nordisks once-weekly injectable GLP-1 for type 2 diabetes recommended for approval, given strong A1c reduction and weight loss
10.1016/j.micpath.2017.07.034 Microb
The case for comprehensive peptide education Regardless of which vendor or compound a researcher chooses, the foundation of good research is understanding the molecules being studied
Nat Protoc 1:712
Heat stress reduces intestinal barrier integrity and favors intestinal glucose transport in growing pigs
It enhances insulin secretion, suppresses glucagon release, and slows the release of contents from the stomach